186 related articles for article (PubMed ID: 28801115)
1. Incidence and prediction of seed migration to the chest after iodine-125 brachytherapy for hepatocellular carcinoma.
Lin J; Yang W; Jiang N; Zheng Q; Huang J; Huang N; Li A; Jiang H
Brachytherapy; 2017; 16(6):1252-1256. PubMed ID: 28801115
[TBL] [Abstract][Full Text] [Related]
2. [Iodin 125 seed migration after prostate brachytherapy: a study of 170 patients].
Chauveinc L; Osseili A; Flam T; Thiounn N; Rosenwald JC; Savignoni A; Cosset JM
Cancer Radiother; 2004 Aug; 8(4):211-6. PubMed ID: 15450513
[TBL] [Abstract][Full Text] [Related]
3. Radioactive seed migration following parotid gland interstitial brachytherapy.
Fan Y; Huang MW; Zhao YJ; Gao H; Zhang JG
Brachytherapy; 2017; 16(6):1219-1224. PubMed ID: 28927732
[TBL] [Abstract][Full Text] [Related]
4. Seed migration after transperineal interstitial prostate brachytherapy with I-125 free seeds: analysis of its incidence and risk factors.
Miyazawa K; Matoba M; Minato H; Morita N; Chikazawa I; Ota K; Tokunaga K; Tonami H; Nojima T; Suzuki K
Jpn J Radiol; 2012 Oct; 30(8):635-41. PubMed ID: 22798169
[TBL] [Abstract][Full Text] [Related]
5. Incidence of seed migration to the chest, abdomen, and pelvis after transperineal interstitial prostate brachytherapy with loose (125)I seeds.
Sugawara A; Nakashima J; Kunieda E; Nagata H; Mizuno R; Seki S; Shiraishi Y; Kouta R; Oya M; Shigematsu N
Radiat Oncol; 2011 Oct; 6():130. PubMed ID: 21974959
[TBL] [Abstract][Full Text] [Related]
6. Reducing seed migration to near zero with stranded-seed implants: Comparison of seed migration rates to the chest in 1000 permanent prostate brachytherapy patients undergoing implants with loose or stranded seeds.
Merrell KW; Davis BJ; Goulet CC; Furutani KM; Mynderse LA; Harmsen WS; Wilson TM; McLaren RH; Deufel CL; Birckhead BJ; Funk RK; McMenomy BP; Stish BJ; Choo CR
Brachytherapy; 2019; 18(3):306-312. PubMed ID: 30853392
[TBL] [Abstract][Full Text] [Related]
7. Implications of radioactive seed migration to the lungs after prostate brachytherapy.
Ankem MK; DeCarvalho VS; Harangozo AM; Hartanto VH; Perrotti M; Han Kr; Shih WJ; Malka E; White EC; Maggio R; Ioffreda R; Goldsmith JW; Weiss RE
Urology; 2002 Apr; 59(4):555-9. PubMed ID: 11927313
[TBL] [Abstract][Full Text] [Related]
8. Pulmonary embolization of permanently implanted radioactive palladium-103 seeds for carcinoma of the prostate.
Nag S; Vivekanandam S; MartÃnez-Monge R
Int J Radiat Oncol Biol Phys; 1997 Oct; 39(3):667-70. PubMed ID: 9336147
[TBL] [Abstract][Full Text] [Related]
9. Radioactive seed migration to the chest after transperineal interstitial prostate brachytherapy: extraprostatic seed placement correlates with migration.
Eshleman JS; Davis BJ; Pisansky TM; Wilson TM; Haddock MG; King BF; Darby CH; Lajoie WN; Oberg AL
Int J Radiat Oncol Biol Phys; 2004 Jun; 59(2):419-25. PubMed ID: 15145158
[TBL] [Abstract][Full Text] [Related]
10. Stranded seed displacement, migration, and loss after permanent prostate brachytherapy as estimated by Day 0 fluoroscopy and 4-month postimplant pelvic x-ray.
Birckhead BJ; Fossum CC; Deufel CL; Furutani KM; Merrell KW; Schueler BA; Mynderse LA; Choo R; Davis BJ
Brachytherapy; 2016; 15(6):714-721. PubMed ID: 27542893
[TBL] [Abstract][Full Text] [Related]
11. [Pulmonary embolization of permanently implanted radioactive iodine-125 seeds for carcinoma of the prostate].
Fukada J; Yorozu A; Toya K; Ohashi T; Sugawara A; Dokiya T
Nihon Igaku Hoshasen Gakkai Zasshi; 2005 Apr; 65(2):121-3. PubMed ID: 15920972
[TBL] [Abstract][Full Text] [Related]
12. Prediction of seed migration after transperineal interstitial prostate brachytherapy with I-125 free seeds.
Sugawara A; Nakashima J; Shigematsu N; Kunieda E; Kubo A
Brachytherapy; 2009; 8(1):52-6. PubMed ID: 19154979
[TBL] [Abstract][Full Text] [Related]
13. Migration of implanted free radioactive seeds for adenocarcinoma of the prostate using a Mick applicator.
Kunos CA; Resnick MI; Kinsella TJ; Ellis RJ
Brachytherapy; 2004; 3(2):71-7. PubMed ID: 15374538
[TBL] [Abstract][Full Text] [Related]
14. Radioactive implant migration in patients treated for localized prostate cancer with interstitial brachytherapy.
Older RA; Synder B; Krupski TL; Glembocki DJ; Gillenwater JY
J Urol; 2001 May; 165(5):1590-2. PubMed ID: 11342923
[TBL] [Abstract][Full Text] [Related]
15. The retrospective analysis of the relationship between prescribed dose and risk factor for seed migration in iodine-125 prostate brachytherapy.
Hirose K; Aoki M; Sato M; Akimoto H; Hashimoto Y; Imai A; Kamimura N; Kawaguchi H; Hatayama Y; Fujioka I; Tanaka M; Ohyama C; Takai Y
Jpn J Radiol; 2016 Nov; 34(11):718-723. PubMed ID: 27631882
[TBL] [Abstract][Full Text] [Related]
16. Migration of prostate brachytherapy seeds to the vertebral venous plexus.
Nakano M; Uno H; Gotoh T; Kubota Y; Ishihara S; Deguchi T; Hayashi S; Matsuo M; Tanaka O; Hoshi H
Brachytherapy; 2006; 5(2):127-30. PubMed ID: 16644468
[TBL] [Abstract][Full Text] [Related]
17. Seed fixity in the prostate/periprostatic region following brachytherapy.
Merrick GS; Butler WM; Dorsey AT; Lief JH; Benson ML
Int J Radiat Oncol Biol Phys; 2000 Jan; 46(1):215-20. PubMed ID: 10656395
[TBL] [Abstract][Full Text] [Related]
18. Scintigraphic detection of 125I seeds after permanent brachytherapy for prostate cancer.
Kono Y; Kubota K; Mitsumoto T; Tanaka A; Ishibashi A; Kobayashi K; Ito K; Itami J; Kanemura M; Minowada S
J Nucl Med; 2008 Apr; 49(4):541-5. PubMed ID: 18344427
[TBL] [Abstract][Full Text] [Related]
19. Prostate brachytherapy seed migration to a left varicocele.
Sugawara A; Nakashima J; Kunieda E; Nagata H; Mizuno R; Seki S; Shiraishi Y; Kouta R; Oya M; Shigematsu N
Brachytherapy; 2012; 11(6):502-6. PubMed ID: 22192493
[TBL] [Abstract][Full Text] [Related]
20. Is scintigraphy necessary to detect migration of 125I seeds after brachytherapy for early prostate cancer?
Odagaki Y; Ohori M; Yoshimura M; Nakshima J; Ohno Y; Mikami R; Nakayama H; Tokuuye K; Tachibana M
Int J Clin Oncol; 2016 Apr; 21(2):397-401. PubMed ID: 26394786
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
